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Abstract
Background: Periodontitis, one of the most prevalent infectious diseases in humans, results in the destruction of
tooth-supporting tissues. The purpose of the present study is to evaluate the effect of cell injection and cell sheet
transplantation on periodontal regeneration in a swine model.
Methods: In the present study, human dental pulp stem cells (hDPSCs) were transplanted into a swine model for
periodontal regeneration. Twelve miniature pigs were used to generate periodontitis with bone defects of 5 mm
in width, 7 mm in length, and 3 mm in depth. hDPSCs were obtained for bone regeneration using cell injection
or cell sheet transplantation. After 12 weeks, clinical, radiological, and histological assessments of regenerated
periodontal tissues were performed to compare periodontal regeneration treated with xenogeneic cell injection
and cell sheet implantation.
Results: Our study showed that translating hDPSCs into this large animal model could significantly improve
periodontal bone regeneration and soft tissue healing. After 12 weeks, both the hDPSC sheet treatment and
hDPSC injection significantly improved periodontal tissue healing clinically in comparison with the control group.
The volume of regenerative bone in the hDPSC sheet group (52.7 ± 4.1 mm3) was significantly larger than in the
hDPSC injection group (32.4 ± 5.1 mm3) (P < 0.05). The percentage of bone in the periodontium in the hDPSC
injection group was 12.8 ± 4.4 %, while it was 17.4 ± 5.3 % in the hDPSC sheet group (P < 0.05).
Conclusion: Both hDPSC injection and cell sheet transplantation significantly regenerated periodontal bone in
swine. The hDPSC sheet had more bone regeneration capacity compared with hDPSC injection.
Keywords: Dental pulp stem cells, Cell injection, Cell sheet, Periodontal bone regeneration
Background
Periodontitis, one of the most prevalent infectious dis-
eases in humans, results in the destruction of tooth-
supporting tissues such as bone, periodontal ligaments,
and cementum [1]. Several regenerative approaches,
including guided tissue regeneration [2], application of
biological mediators such as enamel matrix derivative
(EMD) [3], and other scaffold-based techniques [4], were
proposed to treat periodontal disease, and favorable re-
sults were obtained in clinical trials and animal models.
Based on recent progress in tissue engineering, ex vivo
expanded mesenchymal stem cells (MSCs) are used in
regenerative medicine because of their potential to
differentiate into multiple lineages [5–9]. Previously, we
generated a swine model of periodontitis [10]. In this
model, we induced significant periodontal tissue regen-
eration using periodontal ligament stem cells (PDLSCs)
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mixed with hydroxyapatite/tricalcium phosphate (HA/
TCP) scaffolds [10], allogeneic PDLSC sheets [11], and
vitamin C (Vc)-treated PDLSC sheets [12]. However, in-
flamed autogenous PDLSCs had markedly dysfunctional
immunomodulatory properties [13]; moreover, sources
of PDLSCs are limited, largely impeding the clinical
application of this approach. Compared to other adult
tissue sources, dental pulp stem cells (DPSCs) are an
easily accessible type of adult dental stem cell. In
addition, they are capable of differentiating into at least
three distinct cell lineages: osteo/odontogenic, adipo-
genic, and neurogenic [14]. Thus, DPSCs are a new and
appropriate cell source for periodontal tissue regener-
ation [15]. In the present study, we transplanted human
DPSCs (hDPSCs) via cell injection and cell sheets,
following good manufacturing practice (GMP) [16], for
the treatment of periodontitis in miniature pigs to evalu-
ate the periodontal tissue regeneration capacity of both
approaches. Because of the close similarity between
minipigs and humans in terms of histology and func-
tions of the orofacial tissues, this experimental design
may yield important preclinical information about the




Twelve inbred male Wuzhishan miniature pigs, 12 months
old and weighing 30–40 kg, were obtained from the
Institute of Animal Science of the Chinese Agriculture
University (Beijing, China). The present study was
approved by the animal care and use committee of Capital
Medical University (Reference number: AEEI-2015-089).
The animal care and experimental procedures were
carried out in accordance with guidelines of the Beijing
Experimental Animal Management Ordinance. All surgi-
cal procedures were performed under general anesthesia
using a combination of 6 mg/kg ketamine chloride and
0.6 mg/kg xylazine (intramuscular injection) before the
experimental procedures.
Culture of hDPSCs under GMP
The hDPSCs were cultured in a GMP-compliant facility
with ISO 8 clean room standards equipped with class II
and class III bio-safety cabinets and all other standard
tissue culture equipment. The xenobiotic-free cell cul-
ture reagents included: animal-free origin collagenase
(Worthington Biochemical Corporation, Lakewood, NJ,
USA), CELLstart, EZPassage Tool, HBSS-Ca/Mg free,
D/F12, TrypLE, xeno-free B27, N2 supplement, MSCGM-
CD and ProFreeze CDM (Invitrogen/Gibco, Carlsbad,
CA, USA), human serum (Innovative Research, Inc., Novi,
Michigan, USA), basic fibroblast growth factor-2 (bFGF-2;
Peprotech, Rocky Hill, NJ, USA), TeSR2 which includes
high levels of bFGF-2 together with transforming
growth factor-β (TGF-β; Stem Cell Technologies,
Vancouver, BC, Canada), and Nutristem Stemedia
(Stemgent, San Diego, USA), which consists of human
recombinant insulin, human serum albumin, transfer-
rin, human fibroblast growth factor, and TGF-β.
Normal human impacted third molars were collected
from adults (19–29 years of age) at the Dental Clinic of
the Beijing Stomatological Hospital under approved
guidelines set by the Research Ethical Committee of
Capital Medical University, China. All patients gave their
written informed consent to participate. Tooth surfaces
were cleaned and cut around the cementum-enamel
junction using sterilized dental fissure burs to reveal the
pulp chamber. The pulp tissue was gently separated
from the crown and root and then digested in collage-
nase for 1 h at 37 °C. Single-cell suspensions were ob-
tained by passing the cells through a 70-μm strainer
(Falcon; BD Labware, Franklin Lakes, NJ, USA). All cells
used in this study were from passage 3–4, which were
15–20 divisions of the primary hDPSCs. The same
passage of hDPSCs was used for each experiment. The
characterization of MSCs, including the expression
profiles of surface molecules, colony forming unit fibro-
blasts (CFU-F) assay, and multi-lineage differentiation,
was performed as previously reported [10] (Additional
file 1: Figure S1).
Making hDPSC sheets
The hDPSCs (1.0 × 105) were subcultured in 60-mm
dishes. According to a previous report [12], 20 mg/ml
Vc was added to the culture medium for the duration of
the experiment. The cells became confluent after 2–3
days in culture. Confluent cells were cultured for 7–10
days until the cells at the edge of the dishes wrapped,
which implied that cell sheets had formed and could be
detached. Samples of the hDPSC sheet were processed
for cell count, histological examination, transmission
electron microscopy (TEM), and scanning electron
microscopy (SEM).
Generation of the periodontitis model and hDPSC
administration
Twelve miniature pigs were used to generate periodon-
titis lesions of the first molars as previously reported
[10, 11] for a total of 24 defects. After clinical assess-
ment, a mucoperiosteal flap was raised and alveolar
bone was removed using a surgical bur to create experi-
mental periodontal bone defects in the mesial region of
the maxilla and mandibular first molars. The alveolar
bone defect was 5 mm in width, 7 mm in length, and
3 mm in depth, and notch-shaped marks were made on
the root surface at the level of the top of the alveolar
crest and the floor of the defect (Additional file 2:
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Figure S2A). Each defect was used as the region of
interest for statistical analysis. Three walls of the bone de-
fect were alveolar bone, and the root surface in the bone
defect (Additional file 2: Figure S2A) was instrumented
using Gracey curettes (Shanghai Kangqiao Dental Instru-
ments Factory, Shanghai, China) to remove all periodontal
ligaments as well as cementum to expose the dentin
surface between two notch-shaped marks. These defects
were then randomly assigned to three groups, each con-
sisting of eight defects in four miniature swine. The shape
of the bone defect was detected by periodontal probe
(bone sounding). The tip of the needle was stopped at the
bottom of the bone defect beneath the periosteum.
hDPSCs were injected into the bottom of the periodontal
bone defects beneath the periosteum (Additional file 2:
Figure S2). The hDPSC injection group was injected with
approximately 1 × 107 hDPSCs in 0.6 ml of 0.9 % NaCl at
three sites (approximately 0.2 ml per site): the mesial side
of the bone defect, the distal side of the bone defect, and
the middle of the bone defect. The control group was
injected with 0.9 % NaCl at the same sites as the hDPSC
injection group. In order to demonstrate the aggregation
of hDPSCs at the bone defect, we also performed iodin-
ated contrast media injection following the same proced-
ure as hDPSC injection. In the hDPSC sheet group,
hDPSC sheets were prepared for tissue regeneration in
vivo based on our previous report [12]; briefly, 1.0 × 105
hDPSCs were cultured in 60-mm dishes with 20.0 μg/ml
Vc for 10–15 days to make a sheet, which contained
approximately 1 × 107 hDPSCs/sheet. The hDPSC sheet
was washed with 0.9 % NaCl repeatedly to remove culture
medium as well as residual Vc. The surgical procedure
and placement of the hDPSCs sheet was performed as fol-
lows: Periodontal defects were surgically prepared on the
mesial roots of the bilateral mandibular first molars. An
intracrevicular incision was made on the buccal aspect,
from distal of the forth premolar to the mesial of the sec-
ond molar. Following elevation of the buccal mucoperios-
teal flap, root planning was performed using Gracey
curettes (Shanghai Kangqiao Dental Instruments Factory,
Shanghai, China). A single layer of hDPSC sheet was then
placed on the denuded root in the bone defect. The
mucoperiosteal flap was repositioned and sutured tightly
at the cemento-enamel junction (CEJ) covering the grafted
cell sheet with Gore-Tex suture (Gore-Tex Suture®
CV-5, W. L. Gore and Associates, Inc., Flagstaff, AZ,
USA). At 12 weeks after transplantation, all animals were
sacrificed, and samples were harvested and fixed with 4 %
paraformaldehyde (Sigma-Aldrich Corp.) and assessed
histologically.
SEM observation
Ex vivo expanded hDPSC sheets grown for 7–10 days
were fixed using 2.5 % glutaraldehyde in 0.1 mol/l
sodium cacodylate buffer (pH 7.2) for 2 h at 4 °C. After
washing with sodium dimethylarsenate buffer, the cells
were post-fixed in 1 % osmium tetroxide, dehydrated
with gradient alcohol, and then incubated with isoamyl
acetate. After gold coating, five samples were examined
using a Hitachi S-520 scanning electron microscope
(Hitachi, Tokyo, Japan).
TEM observation
Harvested hDPSCs and hDPSC sheets were fixed using
2.5 % glutaraldehyde in 0.1 mg/ml sodium cacodylate
buffer (pH 7.2) for 2 h at 4 °C. After fixation, three
samples were rinsed three times with 0.1 mol/l sodium
cacodylate buffer (pH 7.2) for 0.5 h. The samples were
post-fixed in 2 % osmium tetroxide, washed for 1 h,
dehydrated in a graded ethanol series, and embedded in
Epon 812 resin according to the manufacturer’s instruc-
tions. Serial 0.5-mm sections were cut and examined
using a light microscope (BHS-RFK; Olympus, Japan)
after staining with 2 % toluidine blue for 5 min. For
TEM analysis, nine 70-nm sections were cut, stained
with 2 % uranylacetate for 30 min and 2 % lead citrate
for 5 min, and observed with a JEM1010 transmission
electron microscope (JEOL, Tokyo, Japan).
Detection and quantitative analysis of implanted hDPSCs
in local periodontal tissue
At 12 weeks after transplantation, all animals were
sacrificed and the samples from the experimental area
were harvested and underwent DNA extraction and
PCR analysis to quantify the numbers of hDPSCs in re-
cipients. Genomic DNA for PCR analysis was prepared
from local alveolar bone and soft tissues in bone defects
using a QIAamp DNAmini kit (Qiagen, Valencia, CA,
USA). The human β-globin gene and the endogenous
miniature pig receptor-associated protein at the synapse
(RAPSYN) gene were amplified with Premix Ex Taq
(probe qPCR) (Takara Bio, Otsu, Japan). For human
β-globin, the forward primer was 5’-GTGCACCT-
GACTCCTGAGGAGA-3’, the reverse primer was 5’-
CCTTGATACCAACCTGCCCAGG-3’, and the probe,
labeled with fluorescent reporter and quencher, was
5’-FAM-AAGGTGAACGTGGATGAAGTTGGTGG-T
AMRA-3’. For miniature pig RAPSYN, the forward
primer was 5’-CTCACTTGTTCTTTCTTCTG -3’, the
reverse primer was 5’-AGCCAGTGTTAGTACCTA-3’,
and the probe was 5’-FAM-TATCTGACCCACCCAT
CCTGC-TAMRA-3’.
Clinical and radiological evaluations
At week 12, the probing depth (PD) and attachment loss
(AL) were evaluated on all experimental teeth pre-
transplantation (week 0) and post-transplantation. The
PD values were established with a Williams periodontal
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probe (Shanghai Kangqiao Dental Instruments Factory,
Shanghai, China). At 4 weeks after operation and
12 weeks after cell implantation, these defects were
examined by computed tomography (CT; Siemens,
Erlangen, Germany) to monitor the defect shape. The
scanning conditions were: 120 kV, 250 mA, 0.75 mm
slice thickness, and 3-s slice acquisition time (Additional
file 2: Figure S2C). Data were stored using the Dicom
3.0 standard. Three-dimensional CT imaging was recon-
structed to assess the tissue regeneration. Dicom format
default images were introduced into Mimics software.
Threshold values were set according to the Bone (CT)
Scale in Mimics. Three-dimensional models were recon-
structed using Optimal, a setting in Mimics. An ASCII
stereolithography (STL) file of the bone was imported
into Geomagic Studio.
Quantitative and histological assessment of regenerated
periodontal tissues
At 12 weeks after transplantation, all animals were sacri-
ficed and the samples from the experimental area were
harvested and fixed with 4 % formaldehyde. The heights
of new bone regeneration were measured using a
Williams periodontal probe: the distance from the top of
the newly formed bone to notch-shaped CEJ marks
made during the operation was scaled. Each sample was
measured at three different positions from the buccal to
the lingual side. Mean values were recorded, and the
heights of new bone regeneration were 7 mm minus
mean values. The proportion of bone volume occupying
the virtual spaces of the defect was measured, allowing
quantitative comparisons among the three groups. Then
the harvested samples were assessed histologically. Five
sites of the hDPSC injection group, five sites of the
control group and five sites of the hDPSC sheet group
were subsequently decalcified with buffered 10 % edetic
acid (pH 8.0) for 8 to 12 weeks and embedded in paraffin.
Sections were deparaffinized and stained with hematoxylin
and eosin (H&E). For histopathological assessment,
buccal-lingual-direction sections of the experimental
region were cut. Sections (5 μm) were deparaffinized and
stained with H&E. For quantification of bone formation,
the extent of bone within each section was analyzed semi-
quantitatively by NIH Image J as described previously
[17]; five representative areas at × 5 magnification in
each group were used. The area of bone formation was
expressed as the percentage of bone in the periodon-
tium in the sections.
Statistical analysis
All statistical calculations were performed with SPSS13
statistical software. The statistical unit was used as the
region of interest. Quantitative data were expressed as
the mean ± standard deviation (SD) and analyzed by
one-way analysis of variance (ANOVA). Statistical signifi-
cance was determined by the independent sample test or
analysis of variance. Comparison between the groups
was made by analyzing data with the post-hoc method.
Statistical significance was set at a level of P < 0.05.
Multiple comparisons between the three groups was
performed using the Student-Newman-Keuls (S-N-K)
test method.
Results
Characterization of hDPSCs and hDPSC sheets under GMP
The cells isolated from dental pulp tissue within each
colony were characterized by a typical fibroblast-like
morphology under GMP conditions. Dental pulp tissue
initially yielded a few cells appearing between 2 and
8 days. The colony forming efficiency was 9–12 % at
14 days of culture. At passage four (after 35 ± 5 days),
each cultured sample (about 0.2 g of pulp tissue) yielded
about 1 × 107 cells. Flow cytometry analysis of hDPSCs
revealed expression of the cell markers CD73, CD105,
CD90, and CD146, but not HLA-DR and CD45
(Additional file 1: Figure S1D). A CT image showed that
injection of iodinated contrast media was localized in
the root surface and periodontal bone defects beneath
the periosteum (Fig. 1a and b; Additional file 2: Figure
S2). H&E staining revealed that the harvested whole
hDPSC sheet contained five or six layers of cells, and
was spread as a membrane-like structure with a uniform
thickness (Fig. 1c). Morphologically, the hDPSC sheet
was wave-shaped, all cells contacted each other tightly
under SEM (Fig. 1d), and the secreted extracellular
matrix (ECM) was around them. Exocytosis vesicles
were observed near the secreted fiber base, demonstrat-
ing the sheet’s cell proliferation and differentiation char-
acteristics (Fig. 1e). TEM of a hDPSC sheet showed
exocytotic vesicles near the plasma membrane. These
data indicated that the obtained hDPSC sheet preserved
the intercellular junctions and endogenous ECM, and
retained their cellular phenotypes.
Both the hDPSC sheet and local injection of hDPSCs
enhanced periodontal soft tissue healing and bone
regeneration in swine
We generated periodontitis lesions in miniature swine
and then transplanted hDPSC sheets or disassociated
cells for tissue regeneration. The animals were sacrificed
at 12 weeks post-transplantation. Intraoral photographs
showed that, 12 weeks after transplantation, marked
periodontal tissue healing was found in the hDPSC in-
jection group (Fig. 2a) and the hDPSC sheet group
(Fig. 2b). There were only limited reattached periodontal
tissues in the control group (Fig. 2c). Three-dimensional
CT images indicated marked bone regeneration in the
hDPSC injection (Fig. 2d) and hDPSC sheet (Fig. 2e)
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groups after cell transplantation, while limited bone for-
mation was seen in the control group (Fig. 2f). Three-
dimensional models at 12 weeks post-transplantation and
pre-transplantation were reconstructed using Mimics
(Additional file 3: Figure S3). The regenerated bone volume
was calculated (Fig. 2g). At 12 weeks post-transplantation,
the AL was 3.1 ± 0.6 mm in the hDPSC sheet group, 3.5 ±
0.6 mm in the hDPSC injection group, and 5.7 ± 0.5 mm in
the untreated control group (Fig. 3b). Statistical analysis
indicated that both hDPSC sheet treatment and hDPSC
injection significantly improved periodontal soft tissue heal-
ing in comparison with the control group (Fig. 3a and b).
The heights of new bone regeneration were significantly
higher in the hDPSC sheet group and hDPSC injection
group than in the control group (Fig. 3c). The CT scan and
three-dimensional CT imaging showed that the volumes of
regenerative alveolar bone in the hDPSC sheet group
and hDPSC injection group were 52.7 ± 4.1 mm3 and
32.4 ± 5.1 mm3, respectively, which were significantly
larger than the volume in the control group (1.8 ±
2.3 mm3, Fig. 2g). At 12 weeks after cell implantation,
experimental tissues were also sectioned in the buccal-
lingual direction and stained with H&E to provide a view
of the entire section. Image J semi-quantitative analysis
showed the percentage of bone in the periodontium in the
hDPSC injection group and hDPSC sheet group were
12.8 ± 4.4 % and 17.4 ± 5.3 %, respectively, which was
significantly larger than the volume in the control group
(7.2 ± 2.0 %) (Fig. 3d). New bone was regenerated in the
hDPSC sheet group (Figs. 3d and 4d) and hDPSC injection
group (Figs. 3d and 4a). A new cementum-like layer from
the height of alveolar bone (HAB) to almost the CEJ was
observed in the hDPSC injection group (Fig. 4a) and
hDPSC sheet group (Fig. 4d). This structure is missing in
the control group (Fig. 4g). There was new attachment of
Sharpy's fibers in the hDPSC sheet group (Fig. 4f) and
hDPSC injection group (Fig. 4c), but attachment was
irregular in the control group (Fig. 4i). Positive human
β-globin expression was found in the tissues from the cell
implantation group, while negative expression was
found in the control group (Fig. 2h).
Comparison of cell sheet transplantation and cell
injection in periodontal regeneration
Although local hDPSC injection significantly improved
periodontal tissue regeneration compared with the con-
trol group, intraoral photographs at 12 weeks post-
injection showed it could not restore tissues to healthy
Fig. 1 Location of injected hDPSCs and hDPSC sheet under good manufacturing practice. After the injection of iodinated contrast media, axial
(a) and sagittal (b) CT slice images demonstrate the aggregation of contrast medium in mandible bone defects (yellow blocks in red dotted line),
which indicated the location of injected hDPSCs beneath the periosteum. c The hDPSCs, induced with 20.0 μg/mL Vc, form a morphologically
complete cell sheet; the cell sheet contained five or six layers and the cells contacted with each other tightly. d Scanning electron microscopy
(SEM) of a hDPSC sheet. Morphologically, the hDPSC sheet was wave-shaped. e SEM of a hDPSC sheet (×1000), all cells contacted each other
tightly. f Transmission electron microscopy (TEM) of a hDPSC sheet. Endogenous ECM (ellipse) was observed between cells
Hu et al. Stem Cell Research & Therapy  (2016) 7:130 Page 5 of 11
levels (Fig. 2a). The height of periodontal alveolar bone
in the hDPSC injection group was 3.8 ± 0.5 mm, while it
was 4.5 ± 0.3 mm in the Vc-mediated hDPSC sheet
group (Fig. 3c). The percentage of bone in the periodon-
tium in the hDPSC sheet group was 17.4 ± 5.3 % while it
was 12.8 ± 4.4 % in the hDPSC injection group (Fig. 3d).
Thus, the periodontal bone regeneration capacity was
greater for the hDPSC sheet.
Discussion
In the present study, we investigated for the first time
the feasibility of using hDPSC injection and hDPSC
sheet implantation for the treatment of periodontitis in a
large animal model. Regeneration of new bone was
detected in both the hDPSC injection group and hDPSC
sheet group 12 weeks after transplantation. In the
control group, periodontal defects were largely restored
by fibrous tissue and epithelia, and limited irregular new
attachment was observed. These results suggested that
the hDPSC injection and hDPSC sheet implantation
contributed significantly more to periodontal tissue
regeneration than in the control group. Intraoral photo-
graphs at 12 weeks post-injection showed hDPSC injec-
tion did not restore tissues to a healthy level compared
with the hDPSC group. CT scan analyses also demon-
strated that the volume of periodontal alveolar bone in
the hDPSC sheet group was significantly larger than
that in the hDPSC injection group. Therefore, the
hDPSC sheet was more effective in periodontal tissue
regeneration.
Fig. 2 Healing of periodontal defects mediated by hDPSCs. a–c Intraoral photographs indicated that, 12 weeks after transplantation, marked periodontal
soft tissue formation was found in the hDPSC injection group (the injection was performed without flap elevation), but could not restore soft tissues to
healthy levels (a) (yellow dotted line). Periodontal soft tissue healing mediated by the hDPSC sheet (b) was close to the normal tissue level (yellow dotted
line). Only limited periodontal soft tissues were recoverd in the control group (c) (yellow dotted line). d–f Three-dimensional CT images revealed marked
bone formation in the hDPSC injection group (d), hDPSCs sheet group (e) after cell transplantation, and limited bone regeneration in the control group
(f) (red dotted lines). g The bone regeneration volumes were larger in the hDPSC sheet group and hDPSC injection group compared with the control
group (*P< 0.05). The bone regeneration volume was larger in the hDPSC sheet group than the hDPSC injection group (△P< 0.05). h Genomic DNA was
extracted from periodontal soft tissue and alveolar bone in the bone defect at 12 weeks after hDPSC implantation. Quantitative PCR was used to detect
the human β-globin gene, and the results were normalized to the miniature pig receptor-associated protein at the synapse (RAPSYN) gene. Results are
shown as means ± SD. *P< 0.05, versus control group. Statistical significance was evaluated by analysis of variance. All error bars represent SD (n= 5).
hDPSC human dental pulp stem cell, M Mesial, W weeks
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The ultimate goal for periodontal therapy is the simul-
taneous regeneration of alveolar bone, cementum, and
periodontal ligament. However, what conventional peri-
odontal therapies, including non-surgical treatments (such
as scaling, root planning) and periodontal flap surgery, can
achieve is no better than arresting the disease process—the
tissue healing ends up in the formation of a long weak
junctional epithelium instead of periodontal attachment.
As a result, conventional periodontal therapies do not lead
to periodontal regeneration, but rather to reattachment via
establishment of long junctional epithelium [18]. As con-
ventional periodontal regeneration methods remain insuffi-
cient to stimulate complete and functional periodontal
regeneration, various regenerative therapies such as
guide tissue regeneration (GTR) have been routinely
utilized together in clinical practice [19, 20]. The GTR
procedure is regarded as the first generation of peri-
odontal regeneration strategy, which functions by pla-
cing a cell-occlusive membrane around the periodontal
defect in order to avoid epithelial downgrowth and to
promote the proliferation of undifferentiated progenitor
cells in the remaining periodontal ligament tissues. The
GTR procedure was improved by the development of
new materials; for example, a novel membrane material
[21]. The bilayered membrane induced greater peri-
odontal regeneration than traditional membranes in a
Fig. 3 Clinical and bone qualitative assessments of regenerated periodontal tissues mediated by hDPSC transplantation in miniature pigs. a, b Clinical
assessments of the periodontal situation in the three groups. At week 0, there was no significant difference in PD (a) and AL (b) among the three groups.
However, at 12 weeks post-transplantation, the PD (a), and AL (b) values were significantly improved in the hDPSC injection and hDPSC sheet groups
compared with the control group. Data are expressed as the mean ± SD (mm). The differences in clinical indexes at each time point among the three
groups were analyzed using one-way analysis of variance. The pairwise comparisons were analyzed using the Bonferroni method (*P <0.05, n= 5). c The
bone regeneration length was highest in the hDPSC sheet group, while the height of bone regeneration in the hDPSC injection group was also higher
than the control group, indicating there was more bone tissue regeneration in the hDPSC injection and hDPSC sheet groups than in the control group
(*P < 0.05). d Semi-quantitative analysis shows the amount of bone formation in each group. The percentage of bone in the periodontium was larger in
the hDPSC sheet group and hDPSC injection group compared with the control group (*P< 0.05); the bone area was larger in the hDPSC sheet group
than that in the hDPSC injection group (△P< 0.05). Statistical significance was evaluated by analysis of variance. All error bars represent SD (n= 5). hDPSC
human dental pulp stem cell, W weeks
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class II furcation defect in dogs. However, patients with
chronic periodontitis are generally middle-aged and
older people, and obviously their progenitor cells of
periodontal tissue are much less active compared with
young donors in terms of the differentiation capacity
and cementum/periodontal ligament-like tissue forma-
tion [22]. Besides, this procedure often involves auto-
graft, allograft, or xenograft transplantation, such as
freeze-dried bone allograft. There are only a few areas
of the body conducive for harvesting autograft tissue.
The problem associated with these allo-/Xeno-biomate-
rial approaches is that the host’s immune system rejects
what it identifies as foreign tissues [23–25]. Autograft,
allograft, and xenograft transplantation may also re-
quire internal fixation which bears the risk of infection
like any other invasive procedure. Therefore, the out-
comes of GTR are limited and associated with poor
clinical predictability [26]. Enamel matrix derivative
(EMD) is regarded as another candidate protein mix-
ture that induces mesenchymal cells to differentiate into
new periodontal tissues [27, 28]. EMD has been demon-
strated to promote periodontal regeneration to a certain
degree, although its true effect remains to be determined
[29–32]. Further well-controlled clinical trials are needed
to justify the clinical application of EMD.
Recent studies have focused on the possible applica-
tion of stem cells and tissue engineering to regenerate
the periodontal structure. Together with the recent pro-
gress in tissue engineering, cell-based therapies have de-
veloped as a foundation for periodontal regenerative
therapy [33]. MSCs are considered as a suitable cell
source for the treatment of periodontitis not only for
their capacity to regenerate different types of tissues, but
also for their paracrine potential, secreting large quan-
tities of growth factors and anti-inflammatory cytokines
such as TGF-β and interleukin (IL)-10 which play im-
portant roles in systemic and local immunomodulation
[34, 35]. Moreover, MSCs have little immunogenicity,
enabling the use of allogeneic cells [34]. In our previous
studies, we demonstrated that allogeneic transplantation
of MSCs into swine periodontal defect models did not
induce immunorejection [36]. Furthermore, we found
that prostaglandin E2 (PGE2) played a crucial role in
PDLSC-mediated immunomodulation and periodontal
tissue regeneration both in vitro and in vivo. PDLSCs
suppressed B-cell activation through cell-to-cell contact,
which was mostly mediated by programmed cell death
protein 1 and programmed cell death 1 ligand 1 [36]. In
the present study, human β-globin gene was still detect-
able at 12 weeks after hDPSC application. However, it is
not sufficient to confirm the presence of live hDPSCs
with the reported PCR result only. Tissue regeneration
may be affected by the species of MSC origin, immuno-
logical status of the host, and presence or absence of
Fig. 4 Histopathological assessment of periodontal bone regeneration by H&E staining. New periodontal bone regeneration in the periodontal
defects of the hDPSC injection group (a) and hDPSC sheet group (d). New bone was regenerated in the periodontal defect area in the hDPSC
injection group (c) and hDPSC sheet group (f). The alveolar bone heights in the hDPSC sheet group and hDPSC injection group were much
larger than those in the control group (i). B bone, C cementum, CEJ cemento-enameljunction, d dentin, HAB height of alveolar bone, hDPSC human
dental pulp stem cell, PDL periodontal ligament, SE sulcular epithelium. However, deep periodontal pockets and shortages of new bone remainedin
the control group (g). Much thicker sulcular epithelia and enlarged epithelial pegs were evident in the control group (h) compared with hDPSC
injection (b) and hDPSC sheet group (e)
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inflammation [37, 38]; the detailed mechanism of how
hDPSCs mediate periodontal regeneration in the pig
model still needs to be further investigated.
Our previous studies have indicated that transplanted
PDLSCs [10–12], stem cells from exfoliated deciduous teeth
(SHED) [39] and bone marrow-derived MSCs (BMMSCs)
[40] can regenerate periodontal tissues, including periodon-
tal ligament and alveolar bone. Among the optional MSCs,
DPSCs have a richer tissue source, and higher proliferating
and colony-forming properties than BMMSCs [41], and are
easier to isolate than PDLSCs. In addition, the DPSC har-
vesting procedure from the extracted third molars is non-
invasive. In the present study, we used xenogeneic DPSCs
cultured under GMP guidelines for periodontal tissue regen-
eration and investigated the feasibility of using hDPSC injec-
tion and hDPSC sheet implantation for the treatment of
periodontitis. Cell injection therapy has been the most com-
mon approach for treating a variety of diseases [42, 43]. In
our previous studies, we used local injection of a BMMSC
suspension in a rat periodontitis model and found tissue de-
fects were repaired [40]. Local injections of MSCs demon-
strated its therapeutic potential in tissue regeneration by
promoting host tissue remodeling [44–47]. The main advan-
tage of MSC injection is that MSCs can be applied to the
periodontal bone defects using minimally invasive surgeries.
“Cell sheet engineering” [48–50] was designed to avoid
the shortcomings of traditional tissue engineering. When
cultured MSCs are harvested as intact sheets along with
their deposited extracellular matrix (ECM), they can be eas-
ily attached to host tissues with minimal cell loss. They also
maintain cell-to-cell and cell-to-ECM connections, which
are generally required to re-create functional tissues. The
preservation and generation of ECM are helpful for tissue
regeneration. Moreover, cell sheet implantation circum-
vents the use of scaffolds, preventing the strong inflam-
matory responses that biodegradable scaffolds would
have incurred. In our previous study [12], we developed
a simple and practical procedure to obtain PDLSC
sheets via a Vc-mediated approach. In this study, new
alveolar bone and periodontal soft tissues were regener-
ated to nearly normal levels 12 weeks after the implant-
ation of hDPSC sheets. However, it requires open flap
surgery which is traumatic for patients. Thus, such
treatment is more suitable in combination with surgi-
cal periodontal treatment.
Conclusions
This study supports the concept of using xenogeneic
DPSCs cultured under GMP guidelines as a potential stem
cell technology for periodontitis. Our data demonstrate
that both xenogeneic DPSC sheets and DPSC injection
can be appropriate therapies for periodontal bone and
soft tissue regeneration.
Additional files
Additional file 1: Figure S1. Characterization of human dental pulp
stem cells (hDPSCs) and the multi-differentiation potentials of hDPSCs.
(A) Representative phase contrast microscopic photographs of hDPSCs
after 14 days; the cultured hDPSCs from single colonies showed typical
fibroblast-like cells under a light microscope. (B) Alkaline phosphatase
activity, an early marker for osteo/dentinogenic differentiation, could be
induced in hDPSCs (Test). (C) Oil red O-positive lipid clusters in hDPSCs
indicated their adipogenic differentiation potential (Test). (D) Flow cytometry
analysis of hDPSCs showed expression of cell markers CD73, CD105, CD90,
and CD146, but not HLA-DR and CD45. (TIF 5686 kb)
Additional file 2: Figure S2. Clinical operation of hDPSC injection.
(A) Clinical assessments of the experimental periodontal bone defect
immediately after osteotomy. (B) Intraoral photograph indicated the injection
process of hDPSCs. (C) As demonstrated on a three-dimensional model, the
suspension of hDPSCs was directly injected in the bottom of the alveolar bone
defect area. (D) CT image showed the location of injected hDPSCs (red arrow).
B bone, hDPSC human dental pulp stem cell. (TIF 4466 kb)
Additional file 3: Figure S3. Three-dimensional CT imaging examination
of bone regeneration. (A) CT Data were stored using the Dicom 3.0 standard
and Dicom format default images were introduced into Mimics software
10.01. (B) Threshold values were set according to the Bone Scale in Mimics.
Three-dimensional models of examined sites were reconstructed using
Optimal, a setting in Mimics. (C) Three-dimensional model of one site. An
ASCII stereolithography (STL) file of the bone was imported into Geomagic
Studio, and excess parts beside the bone defect were roughly removed.
(D) Cutted three-dimensional mode before and 12 weeks after operation of
the same site were imported into Geomagic Studio. (E) N point fitting (n> 5)
was used to overlap the three-dimensional model of the same site before and
12 weeks after operation. (F) Fully overlapped three-dimensional model of the
same site before and 12 weeks after operation; extra areas beside bone
defects were removed in accordance with the same parameters. Bone
regeneration volume was then outputted. Grey model: Three-dimensional
model before operation. Blue model: Three-dimensional model 12 weeks after
operation. (TIF 3799 kb)
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